Diagnostics / News

Diagnostics News

Filtered:

(Remove filters)

Better kidney markers ahead?

This is the question asked in a journalistic article recently published by College of American Pathologists.
The journalist has interviewed a handful of the worlds leading kidney researchers about their outlook on a future where earlier diagnosis and management of acute kidney injury is possible. The article gives an excellent review and status update on NGAL.

Please read the article here -

Better biomarkers ahead?

Read more
Category
Diagnostics, Research
Date

The NGAL Test™ presented at IFCC 2011

Dako Denmark A/S, Reagent Partnership Division, presented data and results of a validation study on The NGAL Test™ at the21st International Congress of Clinical Chemistry and Laboratory Medicine (IFCC-World Lab) in Berlin.

Read more
Category
Diagnostics, Congress news
Date

The NGAL Test™ now launched for diagnostic use in Europe

BioPorto has CE-marked and is now launching The NGAL Test™ for diagnostic use in Europe.

Read more
Category
Diagnostics
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date

The NGAL Test presented at BRS

BioPorto Diagnostics is proud to announce a scientific poster presentation at the BRS/RA Conference in Manchester that includes data obtained with The NGAL Test...

Read more
Category
Diagnostics, Congress news
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date

The NGAL Test presented at ISICEM

BioPorto Diagnostics announces the presentation of a new scientific study that includes data obtained with The NGAL Test - the company's forthcoming diagnostic test for acute kidney injury...

Read more
Category
Diagnostics, Congress news
Clinical Relevance
Intensive care (ICU), Emergency room, Major organ surgery, Transplantation, Nephrotoxicity
Date